Literature DB >> 11797013

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.

Yasuhiko Minokoshi1, Young-Bum Kim, Odile D Peroni, Lee G D Fryer, Corinna Müller, David Carling, Barbara B Kahn.   

Abstract

Leptin is a hormone secreted by adipocytes that plays a pivotal role in regulating food intake, energy expenditure and neuroendocrine function. Leptin stimulates the oxidation of fatty acids and the uptake of glucose, and prevents the accumulation of lipids in nonadipose tissues, which can lead to functional impairments known as "lipotoxicity". The signalling pathways that mediate the metabolic effects of leptin remain undefined. The 5'-AMP-activated protein kinase (AMPK) potently stimulates fatty-acid oxidation in muscle by inhibiting the activity of acetyl coenzyme A carboxylase (ACC). AMPK is a heterotrimeric enzyme that is conserved from yeast to humans and functions as a 'fuel gauge' to monitor the status of cellular energy. Here we show that leptin selectively stimulates phosphorylation and activation of the alpha2 catalytic subunit of AMPK (alpha2 AMPK) in skeletal muscle, thus establishing a previously unknown signalling pathway for leptin. Early activation of AMPK occurs by leptin acting directly on muscle, whereas later activation depends on leptin functioning through the hypothalamic-sympathetic nervous system axis. In parallel with its activation of AMPK, leptin suppresses the activity of ACC, thereby stimulating the oxidation of fatty acids in muscle. Blocking AMPK activation inhibits the phosphorylation of ACC stimulated by leptin. Our data identify AMPK as a principal mediator of the effects of leptin on fatty-acid metabolism in muscle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11797013     DOI: 10.1038/415339a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  529 in total

1.  Leptin: a novel therapeutic role in lipodystrophy.

Authors:  D B Savage; S O'Rahilly
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.

Authors:  Eva Tomas; Tsu-Shuen Tsao; Asish K Saha; Heather E Murrey; Cheng cheng Zhang Cc; Samar I Itani; Harvey F Lodish; Neil B Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

Review 3.  Genetic approaches to understanding human obesity.

Authors:  Shwetha Ramachandrappa; I Sadaf Farooqi
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

4.  The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.

Authors:  Kathleen Mulligan; Hootan Khatami; Jean-Marc Schwarz; Giorgos K Sakkas; Alex M DePaoli; Viva W Tai; Michael J Wen; Grace A Lee; Carl Grunfeld; Morris Schambelan
Journal:  J Clin Endocrinol Metab       Date:  2009-01-27       Impact factor: 5.958

5.  C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance.

Authors:  Xia Lei; Marcus M Seldin; Hannah C Little; Nicholas Choy; Thomas Klonisch; G William Wong
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

6.  GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.

Authors:  Ko Kotani; Odile D Peroni; Yasuhiko Minokoshi; Olivier Boss; Barbara B Kahn
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

7.  Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion.

Authors:  Judy A Butler; Tory M Hagen; Régis Moreau
Journal:  Arch Biochem Biophys       Date:  2009-02-20       Impact factor: 4.013

8.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  Acute, but not chronic, leptin treatment induces acyl-CoA oxidase in C2C12 myotubes.

Authors:  Roberta Ceci; Stefania Sabatini; Guglielmo Duranti; Isabella Savini; Luciana Avigliano; Antonello Rossi
Journal:  Eur J Nutr       Date:  2007-06-14       Impact factor: 5.614

10.  Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy.

Authors:  Rebecca J Brown; Areli Valencia; Megan Startzell; Elaine Cochran; Peter J Walter; H Martin Garraffo; Hongyi Cai; Ahmed M Gharib; Ronald Ouwerkerk; Amber B Courville; Shanna Bernstein; Robert J Brychta; Kong Y Chen; Mary Walter; Sungyoung Auh; Phillip Gorden
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.